About Spiration
Spiration is a company based in Redmond (United States) founded in 1999 was acquired by Olympus America in June 2010.. Spiration has raised $73.9 million across 6 funding rounds from investors including Boston Scientific, Credit Suisse and New Leaf Venture Partners. The company has 74 employees as of December 31, 2015. Spiration offers products and services including Spiration Valve System. Spiration operates in a competitive market with competitors including Pulmonx, Neurent Medical, Gradient Denervation Technologies, Uptake Medical and Emphasys Medical, among others.
- Headquarter Redmond, United States
- Employees 74 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spiration, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$73.9 M (USD)
in 6 rounds
-
Latest Funding Round
$6.5 M (USD), Debt – Conventional
Apr 29, 2010
-
Investors
Boston Scientific
& 8 more
-
Employee Count
74
as on Dec 31, 2015
-
Acquired by
Olympus America
(Jun 25, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spiration
Spiration offers a comprehensive portfolio of products and services, including Spiration Valve System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Minimally-invasive therapy to treat severe emphysema via valve placement
Funding Insights of Spiration
Spiration has successfully raised a total of $73.9M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6.5 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $6.5M
-
First Round
First Round
(20 Nov 2002)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2010 | Amount | Debt – Conventional - Spiration | Valuation |
investors |
|
| Apr, 2010 | Amount | Series G - Spiration | Valuation |
investors |
|
| Sep, 2009 | Amount | Debt – Conventional - Spiration | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spiration
Spiration has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Credit Suisse and New Leaf Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spiration
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spiration
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spiration Comparisons
Competitors of Spiration
Spiration operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Neurent Medical, Gradient Denervation Technologies, Uptake Medical and Emphasys Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of smart devices for treating pulmonary diseases
|
|
| domain | founded_year | HQ Location |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| domain | founded_year | HQ Location |
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
|
| domain | founded_year | HQ Location |
Endobronchial valves for emphysema treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Spiration
When was Spiration founded?
Spiration was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Where is Spiration located?
Spiration is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Is Spiration a funded company?
Spiration is a funded company, having raised a total of $73.9M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $7M, raised on Nov 20, 2002.
How many employees does Spiration have?
As of Dec 31, 2015, the latest employee count at Spiration is 74.
What does Spiration do?
Spiration, develops medical devices for the treatment of air leaks and lung diseases. It developed the IBV Valve system to treat severely diseased lung in patients with heterogeneous emphysema and evidence or markers of low collateral ventilation such as complete fissures, or damaged lung resulting in air leaks, by limiting airflow to selected areas. The Spiration Valve blocks incoming breath from entering damaged portions of the lung, while it permits trapped air and mucus to escape the damaged and potentially hyper-inflated lung. It has received CE Mark regulatory approval, TGA approval in Australia, a humanitarian device exemption for treating prolonged air leaks in the United States, and CFDA approval in China and Health Canada approval for treating air leaks. As of 2010, Spiration operates as a subsidiary of Olympus America.
Who are the top competitors of Spiration?
Spiration's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.
What products or services does Spiration offer?
Spiration offers Spiration Valve System.
Who are Spiration's investors?
Spiration has 9 investors. Key investors include Boston Scientific, Credit Suisse, New Leaf Venture Partners, Olympus America, and Versant Ventures.